Clinical Trial Update: Cabozantinib to Treat Recurrent Liver Cancer Post Transplant [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study of cabozantinib for recurrent hepatocellular carcinoma in liver transplant patients, and it is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• cabozantinib (cabozantinib)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hepatocellular Carcinoma, Recurrent Cancer | Phase 2 | Status: RECRUITING